The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 07, 2026

Filed:

Apr. 10, 2025
Applicant:

James Martin Swanson, Seattle, WA (US);

Inventor:

James Martin Swanson, Seattle, WA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 9/48 (2006.01); A61K 31/135 (2006.01); A61K 31/138 (2006.01); A61K 31/16 (2006.01); A61K 31/165 (2006.01); A61K 31/407 (2006.01); A61K 31/4168 (2006.01); A61K 31/4458 (2006.01); A61K 31/5375 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 9/4808 (2013.01); A61K 31/135 (2013.01); A61K 31/138 (2013.01); A61K 31/16 (2013.01); A61K 31/165 (2013.01); A61K 31/407 (2013.01); A61K 31/4168 (2013.01); A61K 31/4458 (2013.01); A61K 31/5375 (2013.01); A61K 31/55 (2013.01);
Abstract

It is proposed that dissipation of relative benefit during long-term treatment is due to long-term tolerance to stimulant medications. To improve adherence and persistence of medication use, it is advantageous to develop medications that are not undermined by long-term tolerance. Disclosed herein in certain implementations are methods for the prevention of accumulated tolerance to stimulant medication for the treatment of ADHD based on two principles: (a) retaining the initial immediate-release component of controlled-release formulations, and (b) replacing the subsequent sustained-release component (i.e., an ascending delivery of stimulant medication to counteract acute tolerance) with a controlled-release component designed to prevent carry-over effects on background tonic dopamine.


Find Patent Forward Citations

Swanson, James. (2026). Prevention of accumulated tolerance to stimulant medication for the treatment of adhd (U.S. Patent No. 12594250). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12594250

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…